TRDA

ENTRADA THERAPEUTICS INC

Healthcare | Micro Cap

-$0.89

EPS Forecast

$5.83

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2026-12-31

Proximilar's AI forecasts

EPS Forecast:

-$0.89

Revenue Forecast:

$5.83

EPS Surprise Forecast:

$0.088

Revenue Surprise Forecast:

-$2

Post-release price volatility - Very high

Post-release Overnight Move:

±10.0%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

58%

Probability of beating revenue consensus:

41%

Probability of beating both EPS & revs consensus:

28%

Probability of missing both EPS & revs consensus:

30%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

-2

Beta (β)

Forward Looking Beta (β):

1.50

Earnings volatility

EPS standard deviation:

$0.44

Revenue standard deviation:

$17

As % of share price:

7.92%

As % of market cap:

8.06% EXTREME UNCERTAINTY

Confidence intervals and percentiles

EPS 95th %ile:

-$0.38

Revenue 95th %ile:

$26

EPS 75th %ile:

-$0.75

Revenue 75th %ile:

$11

EPS 25th %ile:

-$1.02

Revenue 25th %ile:

$1

EPS 5th %ile:

-$1.44

Revenue 5th %ile:

-$11

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

33% MEDIUM

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

32% HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$65

Bid-ask per Share:

$0.035